{"text": ["Novartis", "Stock", "Is", "Poised", "to", "Rise", "Another", "15%", "From", "Here"], "created_at": "2019-01-08 15:11:00"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/08/2019:", "AXSM,", "AKRX,", "NVS,", "JNJ,", "PFE,", "MRK,", "ABT,", "AMGN"], "created_at": "2019-01-08 14:39:25"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/08/2019:", "AXSM,", "AKRX,", "NVS,", "JNJ,", "PFE,", "MRK,", "ABT,", "AMGN"], "created_at": "2019-01-08 14:39:25"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Amgen", "Slashes", "Cholesterol", "Drug", "Device", "Prices", "By", "60%,", "Takeda", "Completes", "Shire", "Purchase"], "created_at": "2019-01-08 13:15:19"}
{"text": ["Novartis", ":", "FDA", "Grants", "Crizanlizumab", "Breakthrough", "Therapy", "Designation"], "created_at": "2019-01-08 01:43:00"}
{"text": ["Novartis", ":", "FDA", "Grants", "Crizanlizumab", "Breakthrough", "Therapy", "Designation"], "created_at": "2019-01-08 01:43:00"}
